New Drug Applications Archive - July 2009
Get news by email or subscribe to our news feeds.
July 1, 2009
- Novartis Receives Complete Response Letter From The US Food And Drug Administration For Its Investigational Vaccine Menveo
- Photocure submits application for marketing approval for Hexvix in USA to the FDA
July 2, 2009
- Discovery Labs Reports On Surfaxin End of Review Meeting With FDA
- Acura and King Receive FDA Complete Response Letter Regarding Acurox
July 7, 2009
- Somaxon Announces $6 Million Private Equity Financing and Acceptance of NDA Resubmission of Silenor for the Treatment of Insomnia
- Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
- New Drug Application for Exenatide Once Weekly Accepted for Review by FDA
July 8, 2009
July 14, 2009
July 15, 2009
July 16, 2009
July 20, 2009
July 22, 2009
July 23, 2009
- Nycomed Announces FDA Filing for Daxas in COPD
- Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and Actos (pioglitazone HCl)
- Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
